Current
74.6×
5-Year Average
169.3×
All-Time High
1643.9×
All-Time Low
6.9×
P/FCF Ratio daily chart for Eli Lilly (LLY)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
P/FCF ratio is not shown for periods when TTM free cash flow was negative.
Historical P/FCF Ratio for Eli Lilly (LLY) from 2001 to 2025
| 2025 | $965.06B | $8.97B | 107.6× | -1248.9× | |
| 2024 | $692.90B | $510.80M | 1356.5× | — | |
| 2023 | $524.27B | −$3.15B | — | — | |
| 2022 | $347.61B | $4.60B | 75.6× | +26.7× | |
| 2021 | $263.42B | $5.39B | 48.9× | +12.9× | |
| 2020 | $161.51B | $4.48B | 36.0× | -0.1× | |
| 2019 | $125.85B | $3.48B | 36.1× | -11.3× | |
| 2018 | $118.93B | $2.51B | 47.5× | +26.7× | |
| 2017 | $88.85B | $4.28B | 20.7× | -0.2× | |
| 2016 | $80.97B | $3.87B | 20.9× | -60.3× | |
| 2015 | $93.13B | $1.15B | 81.2× | +56.6× | |
| 2014 | $76.62B | $3.11B | 24.6× | +12.4× | |
| 2013 | $56.96B | $4.64B | 12.3× | -0.8× | |
| 2012 | $56.55B | $4.33B | 13.1× | +4.7× | |
| 2011 | $46.37B | $5.54B | 8.4× | +1.5× | |
| 2010 | $38.86B | $5.67B | 6.9× | -4.4× | |
| 2009 | $39.21B | $3.48B | 11.3× | +4.3× | |
| 2008 | $44.08B | $6.35B | 6.9× | -7.3× | |
| 2007 | $58.20B | $4.07B | 14.3× | -5.2× | |
| 2006 | $56.51B | $2.90B | 19.5× | -80.3× | |
| 2005 | $61.45B | $615.50M | 99.8× | +36.7× | |
| 2004 | $61.37B | $971.40M | 63.2× | +24.1× | |
| 2003 | $75.89B | $1.94B | 39.1× | -33.5× | |
| 2002 | $68.26B | $939.80M | 72.6× | +42.2× | |
| 2001 | $84.56B | $2.78B | 30.4× | — |
- 2025107.6×
- 20241356.5×
- 2023—
- 202275.6×
- 202148.9×
- 202036.0×
- 201936.1×
- 201847.5×
- 201720.7×
- 201620.9×
- 201581.2×
- 201424.6×
- 201312.3×
- 201213.1×
- 20118.4×
- 20106.9×
- 200911.3×
- 20086.9×
- 200714.3×
- 200619.5×
- 200599.8×
- 200463.2×
- 200339.1×
- 200272.6×
- 200130.4×
About P/FCF Ratio at Eli Lilly (LLY)
Eli Lilly (LLY) P/FCF ratio is 74.6× as of June 5, 2026. The 5-year average is 169.3×. The sector median currently stands at 19.8×. The current ratio is at the 60th percentile of its own 10-year history.
Eli Lilly (LLY) historical P/FCF ratio has ranged from a low of 6.9× (2010) to a high of 1643.9× (2025) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Eli Lilly P/FCF Ratio by Year
Eli Lilly P/FCF Ratio 2025: 107.6×
Eli Lilly (LLY) P/FCF ratio in 2025 was 107.6×, contracted from 1356.5× the prior year.
Eli Lilly P/FCF Ratio 2024: 1356.5×
Eli Lilly (LLY) P/FCF ratio in 2024 was 1356.5×, expanded from 75.6× the prior year.
Eli Lilly P/FCF Ratio 2022: 75.6×
Eli Lilly (LLY) P/FCF ratio in 2022 was 75.6×, expanded from 48.9× the prior year.
Eli Lilly P/FCF Ratio 2021: 48.9×
Eli Lilly (LLY) P/FCF ratio in 2021 was 48.9×, expanded from 36.0× the prior year.
Eli Lilly P/FCF Ratio 2020: 36.0×
Eli Lilly (LLY) P/FCF ratio in 2020 was 36.0×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Eli Lilly (LLY), ranked by P/FCF ratio.
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric